Greeley Tribune, Greeley Tribune News, Greeley Tribune Sports

Walgreens invested $ 140 million in Theranos.

Drug store giant Temple Walgreens paid انو 100 million to Thiranos, who started a blood test for Palo Alto, and invested an additional 40 40 million in the failed company, a former Walgreens executive said Wednesday to Elizabeth Holmes, founder of Theranos. Testified in criminal fraud case.

Walgreens agreed in 2012 to pay Theranos a 100 million “innovation fee” and an additional 1 million investment agreement to store Thirinos’ blood testing services in Walgreens stores across the United States. Former U.S. Chief Financial Officer Wade McCullen testified at the U.S. District Court in San Jose

Under the deal, Walgreens would immediately pay Theranos ڈالر 25 million, the same amount as when a pilot project killed 10 patients per day, and the remaining مل 50 million after the massive launch of testing services in stores. Agreement displayed in the courtroom

The patient’s trial began in late 2013 in Palo Alto and Arizona, according to McLean, a bowling man in a navy suit, a light gray shirt and a striped blue tie. “The patient feedback we’re getting is very good,” Michalon said during the annual Walgreens call with analysts a month after the test began, according to a transcript of the call that appeared on courtroom screens.

According to an email shown to the judges, by 2014, Holmes was asking Walgreens to hurry up to pay the remaining amount, and was suggesting that a national rollout in Chinese stores could be completed this year. ۔

Holmes, who left Stanford University and founded Theranos in 2003, has been accused of diverting investors from millions of dollars and misleading patients and doctors with false claims that Theranos’ machines are only for blood. You can do a full test using a few drops. He has been charged with a dozen counts of fraud with a finger stick and has pleaded not guilty. Holmes, who gave birth to a baby in the summer, appears in court with his mother, Noel, and sometimes his partner, Billy Evans, who sits in the front row of the gallery directly behind Holmes.

McLean testified that when he began working with Theranos, the now dysfunctional startup now appears to be leading the way in delivering fast, easy, affordable blood testing to more than 150 companies, and that its technology “Really interesting.” But in 2016, Walgreens ended the partnership and sued Theranos, eventually reaching a temporary settlement of less than 30 30 million, the Wall Street Journal reported. Reported In 2017.

%d bloggers like this: